≡

Cyclin Dependent Kinase 2 (CDK2)

[Edit]

CDKN2; p33(CDK2); Cell division protein kinase 2; p33 protein kinase

Cyclin Dependent Kinase 2 (CDK2)
CCC B889
HGNC 1771
MGI 104772
PubMed 1396589
RGD 70486
UniProt P24941
Wiki CDK2

Cyclin-dependent kinase 2 is a member of the cyclin-dependent kinase family of Ser/Thr protein kinases. This protein kinase is highly similar to the gene products of S. cerevisiae cdc28, and S. pombe cdc2. It is a catalytic subunit of the cyclin-dependent kinase complex, whose activity is restricted to the G1-S phase of the cell cycle, and is essential for the G1/S transition. This protein associates with and is regulated by the regulatory subunits of the complex including cyclin E or A. Cyclin E binds G1 phase Cdk2, which is required for the transition from G1 to S phase while binding with Cyclin A is required to progress through the S phase. Its activity is also regulated by phosphorylation. Two alternatively spliced variants and multiple transcription initiation sites of this gene have been reported.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPB889Hu01 Recombinant Cyclin Dependent Kinase 2 (CDK2) Positive Control; Immunogen; SDS-PAGE; WB.
RPB889Hu02 Recombinant Cyclin Dependent Kinase 2 (CDK2) Positive Control; Immunogen; SDS-PAGE; WB.
RPB889Hu03 Recombinant Cyclin Dependent Kinase 2 (CDK2) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAB889Hu01 Polyclonal Antibody to Cyclin Dependent Kinase 2 (CDK2) WB; IHC; ICC; IP.
MAB889Hu22 Monoclonal Antibody to Cyclin Dependent Kinase 2 (CDK2) WB; IHC; ICC; IP.
LAB889Hu81 FITC-Linked Polyclonal Antibody to Cyclin Dependent Kinase 2 (CDK2) WB; IHC; ICC; IF.
LAB889Hu71 Biotin-Linked Polyclonal Antibody to Cyclin Dependent Kinase 2 (CDK2) WB; IHC; ICC.
PAB889Hu03 Polyclonal Antibody to Cyclin Dependent Kinase 2 (CDK2) WB; IHC; ICC; IP.
PAB889Hu02 Polyclonal Antibody to Cyclin Dependent Kinase 2 (CDK2) WB; IHC; ICC; IP.
Assay Kits SEB889Hu ELISA Kit for Cyclin Dependent Kinase 2 (CDK2) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPB889Mu01 Recombinant Cyclin Dependent Kinase 2 (CDK2) Positive Control; Immunogen; SDS-PAGE; WB.
RPB889Mu02 Recombinant Cyclin Dependent Kinase 2 (CDK2) Positive Control; Immunogen; SDS-PAGE; WB.
RPB889Mu03 Recombinant Cyclin Dependent Kinase 2 (CDK2) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAB889Mu01 Polyclonal Antibody to Cyclin Dependent Kinase 2 (CDK2) WB; IHC; ICC; IP.
PAB889Mu02 Polyclonal Antibody to Cyclin Dependent Kinase 2 (CDK2) WB; IHC; ICC; IP.
LAB889Mu71 Biotin-Linked Polyclonal Antibody to Cyclin Dependent Kinase 2 (CDK2) WB; IHC; ICC.
PAB889Mu03 Polyclonal Antibody to Cyclin Dependent Kinase 2 (CDK2) WB; IHC; ICC; IP.
Assay Kits n/a CLIA Kit for Cyclin Dependent Kinase 2 (CDK2) CLIA Kit Customized Service Offer
n/a ELISA Kit for Cyclin Dependent Kinase 2 (CDK2) ELISA Kit Customized Service Offer

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPB889Ra01 Recombinant Cyclin Dependent Kinase 2 (CDK2) Positive Control; Immunogen; SDS-PAGE; WB.
RPB889Ra02 Recombinant Cyclin Dependent Kinase 2 (CDK2) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAB889Ra01 Polyclonal Antibody to Cyclin Dependent Kinase 2 (CDK2) WB; IHC; ICC; IP.
LAB889Ra81 FITC-Linked Polyclonal Antibody to Cyclin Dependent Kinase 2 (CDK2) WB; IHC; ICC; IF.
LAB889Ra71 Biotin-Linked Polyclonal Antibody to Cyclin Dependent Kinase 2 (CDK2) WB; IHC; ICC.
PAB889Ra02 Polyclonal Antibody to Cyclin Dependent Kinase 2 (CDK2) WB; IHC; ICC; IP.
Assay Kits SEB889Ra ELISA Kit for Cyclin Dependent Kinase 2 (CDK2) Enzyme-linked immunosorbent assay for Antigen Detection.
  1. "A new human p34 protein kinase, CDK2, identified by complementation of a cdc28 mutation in Saccharomyces cerevisiae, is a homolog of Xenopus Eg1."EMBO J. 10:2653-2659(1991) [PubMed] [Europe PMC] [Abstract]
  2. "Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase."Nature 353:174-177(1991) [PubMed] [Europe PMC] [Abstract]
  3. "Cloning of a human cDNA encoding a CDC2-related kinase by complementation of a budding yeast cdc28 mutation."Proc. Natl. Acad. Sci. U.S.A. 88:9006-9010(1991) [PubMed] [Europe PMC] [Abstract]
  4. "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
  5. "The finished DNA sequence of human chromosome 12." Nature 440:346-351(2006) [PubMed] [Europe PMC] [Abstract]
  6. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  7. "Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15."EMBO J. 11:3995-4005(1992) [PubMed] [Europe PMC] [Abstract]
  8. "Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5."Eur. J. Biochem. 243:527-536(1997) [PubMed] [Europe PMC] [Abstract]
  9. "Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1."Cell 98:859-869(1999) [PubMed] [Europe PMC] [Abstract]
  10. "Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication."Cell 103:127-140(2000) [PubMed] [Europe PMC] [Abstract]
  11. "NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription."Genes Dev. 14:2283-2297(2000) [PubMed] [Europe PMC] [Abstract]
  12. "Cell cycle-regulated phosphorylation of p220(NPAT) by cyclin E/Cdk2 in Cajal bodies promotes histone gene transcription."Genes Dev. 14:2298-2313(2000) [PubMed] [Europe PMC] [Abstract]
  13. "The C-terminal regulatory domain of p53 contains a functional docking site for cyclin A."J. Mol. Biol. 300:503-518(2000) [PubMed] [Europe PMC] [Abstract]
  14. "Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop."Mol. Cell. Biol. 21:88-99(2001) [PubMed] [Europe PMC] [Abstract]
  15. "Characterization and expression of mammalian cyclin b3, a prepachytene meiotic cyclin."J. Biol. Chem. 277:41960-41969(2002) [PubMed] [Europe PMC] [Abstract]
  16. "Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2."J. Cell Biol. 157:357-366(2002) [PubMed] [Europe PMC] [Abstract]
  17. "Human Spy1 promotes survival of mammalian cells following DNA damage."Cancer Res. 63:3701-3707(2003) [PubMed] [Europe PMC] [Abstract]
  18. "Spy1 interacts with p27Kip1 to allow G1/S progression."Mol. Biol. Cell 14:3664-3674(2003) [PubMed] [Europe PMC] [Abstract]
  19. "NIRF induces G1 arrest and associates with Cdk2."Biochem. Biophys. Res. Commun. 319:464-468(2004) [PubMed] [Europe PMC] [Abstract]
  20. "Liver tumors escape negative control of proliferation via PI3K/Akt-mediated block of C/EBP alpha growth inhibitory activity."Genes Dev. 18:912-925(2004) [PubMed] [Europe PMC] [Abstract]
  21. "p42, a novel cyclin-dependent kinase-activating kinase in mammalian cells."J. Biol. Chem. 279:4507-4514(2004) [PubMed] [Europe PMC] [Abstract]
  22. "Identification and comparative analysis of multiple mammalian Speedy/Ringo proteins."Cell Cycle 4:155-165(2005) [PubMed] [Europe PMC] [Abstract]
  23. "CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair."Nature 434:598-604(2005) [PubMed] [Europe PMC] [Abstract]
  24. "Recognition of Cdk2 by Cdk7."Proteins 67:1048-1059(2007) [PubMed] [Europe PMC] [Abstract]
  25. "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle."Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract]
  26. "Cyclin A/cdk2 coordinates centrosomal and nuclear mitotic events."Oncogene 27:4261-4268(2008) [PubMed] [Europe PMC] [Abstract]
  27. "Identification and characterization of CAC1 as a novel CDK2-associated cullin."Cell Cycle 8:3544-3553(2009) [PubMed] [Europe PMC] [Abstract]
  28. "Large-scale proteomics analysis of the human kinome."Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed] [Europe PMC] [Abstract]
  29. "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]
  30. "Lysine acetylation targets protein complexes and co-regulates major cellular functions."Science 325:834-840(2009) [PubMed] [Europe PMC] [Abstract]
  31. "Nuclear targeting of cyclin-dependent kinase 2 reveals essential roles of cyclin-dependent kinase 2 localization and cyclin E in vitamin D-mediated growth inhibition."Endocrinology 151:896-908(2010) [PubMed] [Europe PMC] [Abstract]
  32. "Cdk2 nitrosylation and loss of mitochondrial potential mediate NO-dependent biphasic effect on HL-60 cell cycle."Free Radic. Biol. Med. 48:851-861(2010) [PubMed] [Europe PMC] [Abstract]
  33. "Cdc25 phosphatases are required for timely assembly of CDK1-cyclin B at the G2/M transition."J. Biol. Chem. 285:16978-16990(2010) [PubMed] [Europe PMC] [Abstract]
  34. "Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2."Nat. Cell Biol. 12:1108-1114(2010) [PubMed] [Europe PMC] [Abstract]
  35. "Cdk2 is required for p53-independent G2/M checkpoint control."PLoS Genet. 6:E1000863-E1000863(2010) [PubMed] [Europe PMC] [Abstract]
  36. "Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation."Proc. Natl. Acad. Sci. U.S.A. 107:58-63(2010) [PubMed] [Europe PMC] [Abstract]
  37. "Initial characterization of the human central proteome."BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract]
  38. "Cep63 recruits Cdk1 to the centrosome: implications for regulation of mitotic entry, centrosome amplification, and genome maintenance."Cancer Res. 71:2129-2139(2011) [PubMed] [Europe PMC] [Abstract]
  39. "Compartmentalized CDK2 is connected with SHP-1 and beta-catenin and regulates insulin internalization."Cell. Signal. 23:911-919(2011) [PubMed] [Europe PMC] [Abstract]
  40. "Discovery of a novel class of 2-aminopyrimidines as CDK1 and CDK2 inhibitors."Bioorg. Med. Chem. Lett. 21:4203-4205(2011) [PubMed] [Europe PMC] [Abstract]
  41. "Deubiquitinase USP37 is activated by CDK2 to antagonize APC(CDH1) and promote S phase entry."Mol. Cell 42:511-523(2011) [PubMed] [Europe PMC] [Abstract]
  42. "An important role for CDK2 in G1 to S checkpoint activation and DNA damage response in human embryonic stem cells."Stem Cells 29:651-659(2011) [PubMed] [Europe PMC] [Abstract]
  43. "A dual role of Cdk2 in DNA damage response."Cell Div. 4:9-9(2009) [PubMed] [Europe PMC] [Abstract]
  44. "Cell cycle, CDKs and cancer: a changing paradigm."Nat. Rev. Cancer 9:153-166(2009) [PubMed] [Europe PMC] [Abstract]
  45. "Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms."Oncogene 28:2925-2939(2009) [PubMed] [Europe PMC] [Abstract]
  46. "Tipping the balance: Cdk2 enables Myc to suppress senescence."Cancer Res. 70:6687-6691(2010) [PubMed] [Europe PMC] [Abstract]
  47. "Cyclin dependent kinase 1 inhibitors: a review of recent progress."Curr. Med. Chem. 18:2025-2043(2011) [PubMed] [Europe PMC] [Abstract]
  48. "N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB."Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012) [PubMed] [Europe PMC] [Abstract]
  49. "Crystal structure of cyclin-dependent kinase 2."Nature 363:595-602(1993) [PubMed] [Europe PMC] [Abstract]
  50. "Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex."Nature 376:313-320(1995) [PubMed] [Europe PMC] [Abstract]
  51. "Crystal structure and mutational analysis of the human CDK2 kinase complex with cell cycle-regulatory protein CksHs1."Cell 84:863-874(1996) [PubMed] [Europe PMC] [Abstract]
  52. "High-resolution crystal structures of human cyclin-dependent kinase 2 with and without ATP: bound waters and natural ligand as guides for inhibitor design."J. Med. Chem. 39:4540-4546(1996) [PubMed] [Europe PMC] [Abstract]
  53. "Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex."Nature 382:325-331(1996) [PubMed] [Europe PMC] [Abstract]
  54. "Structural basis of cyclin-dependent kinase activation by phosphorylation."Nat. Struct. Biol. 3:696-700(1996) [PubMed] [Europe PMC] [Abstract]
  55. "Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase."Proc. Natl. Acad. Sci. U.S.A. 93:2735-2740(1996) [PubMed] [Europe PMC] [Abstract]
  56. "Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2."Nat. Struct. Biol. 4:796-801(1997) [PubMed] [Europe PMC] [Abstract]
  57. "Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors."Science 281:533-538(1998) [PubMed] [Europe PMC] [Abstract]
  58. "Triazolo[1,5-a]pyrimidines as novel CDK2 inhibitors: protein structure-guided design and SAR."Bioorg. Med. Chem. Lett. 16:1353-1357(2006) [PubMed] [Europe PMC] [Abstract]
  59. "Discovery of a potent CDK2 inhibitor with a novel binding mode, using virtual screening and initial, structure-guided lead scoping."Bioorg. Med. Chem. Lett. 17:3880-3885(2007) [PubMed] [Europe PMC] [Abstract]
  60. "Cyclin B and cyclin A confer different substrate recognition properties on CDK2."Cell Cycle 6:1350-1359(2007) [PubMed] [Europe PMC] [Abstract]
  61. "How tyrosine 15 phosphorylation inhibits the activity of cyclin-dependent kinase 2-cyclin A."J. Biol. Chem. 282:3173-3181(2007) [PubMed] [Europe PMC] [Abstract]
  62. "Structure-guided discovery of cyclin-dependent kinase inhibitors."Biopolymers 89:372-379(2008) [PubMed] [Europe PMC] [Abstract]
  63. "Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug design." J. Med. Chem. 51:4986-4999(2008) [PubMed] [Europe PMC] [Abstract]
  64. "Briefly bound to activate: transient binding of a second catalytic magnesium activates the structure and dynamics of CDK2 kinase for catalysis."Structure 19:675-690(2011) [PubMed] [Europe PMC] [Abstract]
  65. "Patterns of somatic mutation in human cancer genomes." Nature 446:153-158(2007) [PubMed] [Europe PMC] [Abstract]
  66. "A role for the Ankyrin repeat containing protein Ankrd17 in Nod1- and Nod2-mediated inflammatory responses."FEBS Lett. 587:2137-2142(2013) [PubMed] [Europe PMC] [Abstract]